Logo

American Heart Association

  8
  0


Final ID: MDP909

Tissue-Engineered Vascular Grafts: Evaluation of Remodeled Neotissue and Its Effect on Flow Dynamics

Abstract Body (Do not enter title and authors here): Background: The Fontan surgery for treating hypoplastic left heart syndrome has significantly improved postoperative mortality. However, the materials commonly used for conduits, such as PTFE, can cause complications, such as graft calcification over long-term follow-up, which causes flow restriction and lower exercise tolerance as clinical complications. To address these issues, we have developed a tissue-engineered vascular graft (TEVG) composed of biodegradable polymers that are replaced by autologous tissue, called "neotissue," which exhibits histological similarity to native vessels(Figure1) and resistance to calcification. We are investigating the functional properties of this neotissue, focusing on distensibility, an essential function accommodating blood volume, and its impact on flow dynamics.
Methods: We evaluated chronic sheep models (6-8 years post-implantation) with thoracic inferior vena cava (IVC) interposition grafts of TEVG (n=5) and PTFE (n=5), as well as age-matched surgically naive sheep (n=5). Using our established in vivo distensibility testing protocol(Figure1b), we measured distensibility in the target regions and compared the groups. Additionally, we utilized the 3D geometries obtained from 3D angiography to create patient-specific computational flow dynamics simulations using a software, SimVascular, allowing us to investigate the impact of distensibility and graft 3D morphology on flow dynamics.
Results: Distensibility measurements showed no significant difference between TEVG (173.67±98.74[%100mmHg]) and native vessels (268.57±199.57), while PTFE grafts (10.35±12.67) exhibited significantly lower compliance compared to the other two groups(Figure1). The 3D fluid model simulations generated by SimVascular revealed that the native IVC revealed uniform dilation and smooth blood flows by fluid stress. TEVGs showed small velocity acceleration in the middle. In contrast, since the PTFE grafts were not distensible, they caused significant flow velocity acceleration and high wall shear stress at the graft region(Figure2,3).
Conclusions: The TEVG neotissue demonstrated significantly higher distensibility than PTFE grafts and was not significantly different from native vessels. The simulation demonstrated that the differences in distensibility in response to fluid volume impact flow dynamics, which relate to the clinical complications of Fontan patients. TEVG has the potential to mitigate these complications.
  • Watanabe, Tatsuya  ( Nationwide Children's Hospital , Columbus , Ohio , United States )
  • Shinoka, Toshiharu  ( Nationwide Children's Hospital , Columbus , Ohio , United States )
  • Breuer, Christopher  ( Nationwide Children's Hospital , Columbus , Ohio , United States )
  • Villarreal, Delaney  ( Nationwide Children's Hospital , Columbus , Ohio , United States )
  • Anderson, Cole  ( Nationwide Children's Hospital , Columbus , Ohio , United States )
  • Yang, Weiguang  ( Stanford University , Palo Alto , California , United States )
  • Guo, Marissa  ( Nationwide Children's Hospital , Columbus , Ohio , United States )
  • Yuhara, Satoshi  ( Nationwide Children's Hospital , Columbus , Ohio , United States )
  • Nelson, Kirsten  ( Nationwide Children's Hospital , Columbus , Ohio , United States )
  • Morrison, Adrienne  ( Nationwide Children's Hospital , Columbus , Ohio , United States )
  • Kelly, John  ( Nationwide Children's Hospital , Columbus , Ohio , United States )
  • Author Disclosures:
    Tatsuya Watanabe: DO NOT have relevant financial relationships | Toshiharu Shinoka: DO have relevant financial relationships ; Research Funding (PI or named investigator):Gunze Ltd.:Active (exists now) | christopher breuer: DO have relevant financial relationships ; Research Funding (PI or named investigator):gunze limited:Active (exists now) ; Other (please indicate in the box next to the company name):Biostage (DSMB member):Active (exists now) ; Other (please indicate in the box next to the company name):Mezzion (DSMB member):Active (exists now) ; Research Funding (PI or named investigator):Pall (Cytiva):Past (completed) | Delaney Villarreal: DO NOT have relevant financial relationships | Cole Anderson: No Answer | Weiguang Yang: No Answer | Marissa Guo: No Answer | Satoshi Yuhara: No Answer | Kirsten Nelson: DO NOT have relevant financial relationships | Adrienne Morrison: No Answer | John Kelly: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Tomorrow's Solutions Today: Discovery Science in Vascular Disease

Sunday, 11/17/2024 , 11:10AM - 12:15PM

Moderated Digital Poster Session

More abstracts on this topic:
Immunologic Insights: Activated and Exhausted Circulating T-Cell Phenotype in Hypoplastic Left Heart Syndrome (HLHS)

Kumah Yvonne, Garcia Anastacia, Abbott Jordan, Lang Julie, Nakano Stephanie

Artificial-Intelligence Based Tracking of Atrial Fibrillation Waves that Exit Pulmonary Veins Predicts Response to Ablation

Anbazhakan Suhaas, Abad Juan Ricardo Carlos, Ruiperez-campillo Samuel, Rodrigo Miguel, Narayan Sanjiv

More abstracts from these authors:
A Tale of Two Surgeries: Single Stage Versus Two Staged Approach to Creating an Ovine Model of Fontan Palliation

Kievert Jennifer, Morrison Adrienne, Nelson Kirsten, Heuer Eric, Shinoka Toshiharu, Breuer Christopher, Carrillo Sergio Alejandro, Kelly John, Spiess Joshua, Deshetler Cameron, Yuhara Satoshi, Watanabe Tatsuya, Jimenez Michael, Naguib Aymen, Mckee Christopher, Yates Andrew

Evaluation of 3D Bioprinted Pulsatile Conduits Engineered Using Human Stem Cell-Derived Cardiomyocytes in a Murine Model

Ashraf Syed Faaz, Breuer Christopher, Feinberg Adam, Bliley Jacqueline, Yi Tai, Leland Joseph, Kang Amanda, Stang Maria, Dikyol Caner, Behre Anne, Tzeng Edith

You have to be authorized to contact abstract author. Please, Login
Not Available